Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Lucid Diagnostics Inc LUCD

Healthcare Medical Devices
Lucid Diagnostics Inc. operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. Its flagship product, the EsoGuard Esophageal DNA Test performed on samples collected with... see more

Current News (NDAQ:LUCD)

Lucid Diagnostics Announces Positive Data from the Largest Reported Real-World Experience of Esophageal Precancer Detection

PR Newswire 2 days ago

Lucid Diagnostics Named a GenomeWeb 2025 Best Places to Work Top-Ranking Honoree

PR Newswire November 20, 2025

Lucid Diagnostics to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

PR Newswire November 13, 2025

PAVmed Provides Business Update and Reports Third Quarter 2025 Financial Results

PR Newswire November 13, 2025

Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results

PR Newswire November 12, 2025

Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on November 12, 2025

PR Newswire October 29, 2025

Lucid Diagnostics to Participate in the 2025 Maxim Growth Summit

PR Newswire October 15, 2025

Lucid Diagnostics Appoints Healthcare Industry Veteran John R. Palumbo to Board of Directors

PR Newswire September 25, 2025

Lucid Diagnostics Appoints Danielle Scelfo as Senior Vice President, Market Access & Government Affairs

PR Newswire September 16, 2025
View More News ››

Opinion & Analysis (NDAQ:LUCD)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LUCD)

Lucid Diagnostics (LUCD) Poised for Breakthrough in Esophage

http://beyondspx.com/2024/08/01/lucid-diagnostics-lucd-poised-for-breakthrough-in-esophageal-cancer-detection/
MikeTester - August 1, 2024
View more Bullboard ››

Interactive Capital Partners Corporation

Interactive Capital Partners Corporation

View More »